PSA density is associated with BPH cellular composition.

Jia, Liwei; Strand, Douglas W; Goueli, Ramy S; Gahan, Jeffrey C; Roehrborn, Claus G; Mauck, Ryan J

Jia, Liwei; Strand, Douglas W; Goueli, Ramy S; Gahan, Jeffrey C; Roehrborn, Claus G; Mauck, Ryan J.

Afiliação

Jia L; Department of Pathology, UT Southwestern Medical Center, Dallas, Texas, USA.
Strand DW; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Goueli RS; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Gahan JC; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Roehrborn CG; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.
Mauck RJ; Department of Urology, UT Southwestern Medical Center, Dallas, Texas, USA.

Prostate ; 82(12): 1162-1169, 2022 09.

Article em En | MEDLINE | ID: mdl-35652548

Assuntos

Hiperplasia Prostática; Inibidores de 5-alfa Redutase/uso terapêutico; Humanos; Masculino; Próstata/patologia; Antígeno Prostático Específico; Hiperplasia Prostática/patologia

Palavras-chave

PSA density; benign prostatic hyperplasia; histology; prostate specific antigen; prostate volume

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hiperplasia Prostática Tipo de estudo: Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google